• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞相关免疫球蛋白样受体-1在细胞毒性T细胞上作为一种抑制性受体发挥作用。

Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells.

作者信息

Meyaard L, Hurenkamp J, Clevers H, Lanier L L, Phillips J H

机构信息

Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304, USA.

出版信息

J Immunol. 1999 May 15;162(10):5800-4.

PMID:10229813
Abstract

Leukocyte associated Ig-like receptor-1 (LAIR-1) is a surface molecule expressed on human mononuclear leukocytes that functions as an inhibitory receptor on human NK cells. In addition to NK cells, LAIR-1 is expressed on T cells, B cells, macrophages, and dendritic cells. Most cells express two biochemically distinct forms of LAIR-1, which we now show are likely alternative splice variants of the same gene. Cross-linking of LAIR-1 on human T cell clones results in inhibition of cytotoxicity only in T cell clones that lack CD28 and are able to spontaneously lyse certain targets in vitro. Moreover, the cytolytic activity of freshly isolated T cells, which is thought to be mainly due to "effector" T cells, can be inhibited by anti-LAIR-1 mAb. Thus, LAIR-1 functions as an inhibitory receptor not only on NK cells, but also on human T cells. This indicates that LAIR-1 provides a mechanism of regulation of effector T cells and may play a role in the inhibition of unwanted bystander responses mediated by Ag-specific T cells.

摘要

白细胞相关免疫球蛋白样受体-1(LAIR-1)是一种在人类单核白细胞上表达的表面分子,它在人类自然杀伤细胞(NK细胞)上作为抑制性受体发挥作用。除了NK细胞外,LAIR-1还在T细胞、B细胞、巨噬细胞和树突状细胞上表达。大多数细胞表达两种生化特性不同的LAIR-1形式,我们现在证明它们可能是同一基因的可变剪接变体。在人类T细胞克隆上交联LAIR-1仅在缺乏CD28且能够在体外自发裂解某些靶标的T细胞克隆中导致细胞毒性抑制。此外,新鲜分离的T细胞的细胞溶解活性(被认为主要归因于“效应”T细胞)可被抗LAIR-1单克隆抗体抑制。因此,LAIR-1不仅在NK细胞上,而且在人类T细胞上都作为抑制性受体发挥作用。这表明LAIR-1提供了一种调节效应T细胞的机制,并且可能在抑制由抗原特异性T细胞介导的不必要的旁观者反应中发挥作用。

相似文献

1
Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells.白细胞相关免疫球蛋白样受体-1在细胞毒性T细胞上作为一种抑制性受体发挥作用。
J Immunol. 1999 May 15;162(10):5800-4.
2
Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.浸润人肺癌的表达KIR3DL2/p140的肿瘤特异性细胞毒性T淋巴细胞克隆的功能和分子特征
Oncogene. 2003 Oct 16;22(46):7192-8. doi: 10.1038/sj.onc.1206627.
3
Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation.人外周血T细胞活化和分化过程中抑制性受体LAIR-1的表达调控
Eur J Immunol. 2007 Apr;37(4):914-24. doi: 10.1002/eji.200636678.
4
A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.关于CD33(唾液酸结合免疫球蛋白样凝集素-3)抗原在活化的人T细胞和NK细胞上的表达及功能的研究:CD33的两种异构体通过可变剪接产生。
J Leukoc Biol. 2006 Jan;79(1):46-58. doi: 10.1189/jlb.0205096.
5
Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.人类自然杀伤细胞亚群上CD28变体的表达:对B7介导的自然杀伤细胞刺激的影响
J Immunol. 1999 Jul 1;163(1):62-70.
6
A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.一种类似于Ly49D激活受体的“嵌合”C57l衍生Ly49抑制性受体。
Cell Immunol. 2001 Apr 10;209(1):29-41. doi: 10.1006/cimm.2001.1786.
7
Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.人宫颈癌中肿瘤浸润性CD8 + T淋巴细胞的抑制性自然杀伤受体CD94/NKG2A上调,同时细胞内穿孔素表达受到抑制。
Cancer Res. 2005 Apr 1;65(7):2921-9. doi: 10.1158/0008-5472.CAN-04-2108.
8
CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.CD8相互作用突变型HLA - Cw3分子可保护猪细胞免受人类自然杀伤细胞介导的抗体依赖性细胞毒性作用,而不会刺激细胞毒性T淋巴细胞。
Transplantation. 2003 Dec 15;76(11):1615-22. doi: 10.1097/01.TP.0000086342.60603.C2.
9
CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.类风湿关节炎患者的CD4+、CD28- T细胞兼具先天性和适应性免疫系统的特征。
Arthritis Rheum. 2001 Jan;44(1):13-20. doi: 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6.
10
Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.大鼠NKp46激活自然杀伤细胞的细胞毒性,并与FcεRIγ和CD3ζ相关。
J Leukoc Biol. 2004 Dec;76(6):1200-6. doi: 10.1189/jlb.0903428. Epub 2004 Sep 8.

引用本文的文献

1
Targeting LAIR1-mediated immunosuppression adds a new weapon to our immunotherapy arsenal.靶向LAIR1介导的免疫抑制为我们的免疫治疗武器库增添了新的武器。
J Clin Invest. 2025 Aug 15;135(16). doi: 10.1172/JCI194924.
2
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.LAIR1作为抗肿瘤免疫细胞反应以及肿瘤细胞生长与增殖的调节性受体的作用。
Biomolecules. 2025 Jun 13;15(6):866. doi: 10.3390/biom15060866.
3
Inhibitory pattern recognition receptors: lessons from LAIR1.抑制性模式识别受体:来自LAIR1的经验教训。
Nat Rev Immunol. 2025 May 27. doi: 10.1038/s41577-025-01181-2.
4
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors.新型 LAIR1 拮抗剂联合抗 PD-1 治疗富含胶原的实体瘤的抗肿瘤活性。
Mol Cancer Ther. 2024 Aug 1;23(8):1144-1158. doi: 10.1158/1535-7163.MCT-23-0866.
5
Barriers to immune cell infiltration in tumors.肿瘤中免疫细胞浸润的障碍。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-006401.
6
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.白细胞相关免疫球蛋白样受体在非小细胞肺癌中的定量、空间表达。
Cancer Res Commun. 2023 Mar 21;3(3):471-482. doi: 10.1158/2767-9764.CRC-22-0334. eCollection 2023 Mar.
7
Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma.蛋白质组学和单细胞图谱揭示了乙肝病毒感染的肝内胆管癌的新致病机制。
iScience. 2023 Jan 18;26(2):106003. doi: 10.1016/j.isci.2023.106003. eCollection 2023 Feb 17.
8
LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms.LAIR1,一种包含 ITIM 的受体,与免疫紊乱和血液系统肿瘤有关。
Int J Mol Sci. 2022 Dec 17;23(24):16136. doi: 10.3390/ijms232416136.
9
Blocking LAIR1 signaling in immune cells inhibits tumor development.阻断免疫细胞中的 LAIR1 信号可抑制肿瘤发展。
Front Immunol. 2022 Sep 21;13:996026. doi: 10.3389/fimmu.2022.996026. eCollection 2022.
10
Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse.补体系统与警报素 HMGB1 的串扰:有好有坏。
Front Immunol. 2022 Apr 28;13:869720. doi: 10.3389/fimmu.2022.869720. eCollection 2022.